Skip to search formSkip to main contentSkip to account menu

ruxolitinib phosphate

Known as: (3R)-3-cyclopentyl-3-(4-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)pyrazol-1-yl)propanenitrile Phosphate (1:1), 1H-Pyrazole-1-propanenitrile, beta-cyclopentyl-4-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-,(betaR)-, phosphate (1:1), INCB-18424 Phosphate 
The phosphate salt form of ruxolitinib, an orally bioavailable Janus-associated kinase (JAK) inhibitor with potential antineoplastic and… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
ABSTRACT Introduction Allogeneic transplantation represents a potentially curative procedure for various lethal conditions… 
Review
2019
Review
2019
e19063 Background: Constitutive activation of the JAK-STAT pathway has been reported in lymphomas, suggesting that targeting this… 
Review
2016
Review
2016
PURPOSE To review the use of patient-reported outcome (PRO) data in medical product labeling granted by the US Food and Drug…